Operating Lease, Right-of-Use Asset of Harmony Biosciences Holdings, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Harmony Biosciences Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Harmony Biosciences Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,228,000, a 47% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Harmony Biosciences Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,228,000 -$1,092,000 -47% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,277,000 -$1,231,000 -49% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $1,726,000 -$1,320,000 -43% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $2,122,000 -$222,000 -9.5% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $2,320,000 -$136,000 -5.5% 30 Sep 2024 10-Q 29 Oct 2024 2024 Q3
Q2 2024 $2,508,000 +$451,000 +22% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $3,046,000 +$662,000 +28% 31 Mar 2024 10-Q 30 Apr 2024 2024 Q1
Q4 2023 $2,344,000 +$32,000 +1.4% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $2,456,000 -$202,000 -7.6% 30 Sep 2023 10-Q 31 Oct 2023 2023 Q3
Q2 2023 $2,057,000 -$928,000 -31% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $2,384,000 -$750,000 -24% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $2,312,000 -$986,000 -30% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $2,658,000 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $2,985,000 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $3,134,000 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $3,298,000 31 Dec 2021 10-K 21 Feb 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.